Description
The market for diabetes-related products is huge and continuing to grow. However, it is not the same market as it was just 3 years ago. New trends in care, new products (both therapeutic and diagnostic), new approaches to long-term complications, and changing public health priorities along with geographic variations are shifting the sands of opportunities in diabetes care.
This comprehensive re-evaluation of the major world market for diabetes monitoring and therapeutic products provides in-depth data and analysis including:
- Detailed epidemiology by country of Type I and II diabetes, with forecasts through 2016
- Market size and growth for each segment and subsegment in each country through 2016
- Thorough discussions of products on the market and evaluations of new products and technologies in development that may change the market of the future
- Considerations of the geographic market variations and very different diabetes care environments to be found in each of the major national markets.
- In-depth profiles of the top competitors and their diabetes-related portfolios
- 17 conclusions and strategic implications competitors in the marketplace must take into account as they formulate future plans
Market data (including size and growth projections) are provided for the major diagnostic and therapeutic segments:
- Glucose Testing
- Insulin
- Oral hypoglycemics
- Antihypertensives for diabetes-related hypertension
- Lipid-lowering drugs for diabetes-related dyslipidemia
- Antiarrhythmics for diabetes-related arrhythmias
- Various drugs for diabetes-related peripheral vascular disease
A truly global report, the major world markets covered in the study include:
- France
- Germany
- Italy
- Japan
- Spain
- United Kingdom
- United States
The analysis presented in this report is based on data from a combination of company, government, industry, institutional, and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including diabetologists, endocrinologists, internists, pathologists, research scientists, business development managers and marketing managers.
